Affibody and Chiesi Group to develop treatments for respiratory diseases
Affibody AB and Chiesi Farmaceutici S.p.A have announced a collaboration and licensing agreement to develop…
March 8, 2023 - 3 minutes
Respiratory disease
Positive results for INOVIO recurrent respiratory papillomatosis trial
INOVIO Pharmaceuticals has announced positive preliminary results from the second cohort of its phase 1/2…
February 17, 2023 - 3 minutes
Poolbeg identifies new potential drug candidates for RSV infections
Poolbeg Pharma says it has successfully identified potential new drug candidates from its respiratory syncytial…
December 21, 2022 - 3 minutes
Watch: Atriva Therapeutics at BIO-Europe
Atriva Therapeutics’ mission is to develop an antiviral therapy platform against severe respiratory and systemic…
December 19, 2022 - 1 minute
Tetra announce significant results from the study of Onternabez combined with Favipiravir
Tetra Bio-Pharma Inc. a leader in cannabinoid-derived drug discovery and development announced today significant results…
December 6, 2022 - 2 minutes
Licensing agreement signed for C4XD between C4X Discovery and AstraZeneca
C4X Discovery Holdings plc has signed an exclusive worldwide licensing agreement with AstraZeneca. It is worth…
November 28, 2022 - 3 minutes
First patients dosed with Infex Therapeutics’ RESP-X for chronic respiratory disease
A new anti-virulence therapy, RESP-X, treating Pseudomonas aeruginosa (Pa) infections in non-cystic fibrosis bronchiectasis (NCFB)…
November 23, 2022 - 3 minutes
Progress of COPD drug boosted by debt financing of up to $150M
Verona Pharma plc has today (October 17) announced that it has entered into a debt…
October 18, 2022 - 2 minutes
Patents granted for Poolbeg Pharma influenza and respiratory virus infections treatments
Poolbeg Pharma has been granted patents by the US Patent and Trademark Office (USPTO) for…
October 4, 2022 - 2 minutes
CHMP recommends approval of Beyfortus for prevention of RSV disease in infants
Beyfortus, which is being developed jointly by Sanofi and AstraZeneca, is a step closer to…
September 16, 2022 - 4 minutes
Synairgen to collaborate on study of patients hospitalized due to respiratory viruses
Synairgen plc is to collaborate on a University of Southampton study on acute respiratory viral…
September 5, 2022 - 3 minutes
Encouraging results from respiratory diseases vaccine trial
A biopharmaceutical company developing vaccines against infectious diseases has announced positive results for people with…
June 29, 2022 - 4 minutes
